Creation
Draft
Initial
Signpost/Archive
Idea Description
Supplementary Information
Innovation 'Elevator Pitch':
The RAPID project is a pioneering research study using real-time diagnostic information inspired by the world of Formula 1.
Vital signs continuously monitored wirelessly and advanced algorithms provide early warinng of deterioration.
Overview of Innovation:
The RAPID (Real-Time Adaptive and Predictive Indicator of Deterioration) project – is the first of its type in the world. It constantly collects data from children on our cardiac wards including their:
  • heart rate
  • breathing rate
  • oxygen levels
This is a new and exciting way for children to be monitored and gives important early warning signs of deterioration that can be acted on quickly. 
The study was based on McLaren’s expertise in using hundreds of sensors to collect and analyse real-time data during a race to optimise its strategy on the track and Aston University's expertise in applied mathematics.
This technology has been adapted to be used in healthcare for the first time. Hi-tech wireless sensors, designed by Isansys Lifecare are attached to the chest and hands/ankle of children to measure vital signs. The information collected is processed in real-time using machine learning techniques developed by mathematicians from Aston University which are embedded into McLaren’s data analytics platform, LIFEINSIGHT™.
This new technology means that signs normally recorded every one to four hours on paper charts could potentially become a thing of the past. Children will have access to continuous individual monitoring that gives more accurate information helping them to receive faster treatment and shorter stays in hospital.
The wireless technology and wearable sensors remove the need for cables and leads, which can restrict effective monitoring. This means parents can hold and interact normally with their child while knowing they are being safely and continuously monitored.
The three-year study was jointly funded by a £1.8 million grant from the Welcome Trust and Department of Health, through the Health Innovation Challenge Fund, started in November 2014, and aims to recruit around 1,200 patients when it reaches its completion in late 2017.
 
Stage of Development:
Trial stage - Trial stage to prove that the idea actually works as intended
Similar Content2
Innovation 'Elevator Pitch':
Sensium accurately & reliably monitors & transmits patients’ vital signs every 2 minutes & notifies of deterioration between Observation rounds. Easy to use, SensiumVitals provides tangible benefits for patients, clinicians & for the hospital.

Overview of Innovation:
In general care areas of a hospital vital signs are typically taken during routine observation rounds once every 4-8 hours. If a patient deteriorates between these observation rounds the warning signs can go undetected for hours, potentially leading to serious & costly consequences.
 
Sensium is a discreet, wearable, wireless system for monitoring vital signs of patients outside of high acuity areas. A light comfortable sensor worn on the patient’s chest accurately & reliably monitors & reports vital signs providing data every 2 minutes. By notifying clinicians of changes in patients’ vital signs Sensium brings the nurse to the deteriorating patient. This includes patients on general wards, post-operative med/surg. wards & patients waiting before & after treatment in A&E departments.
 
Sensium Patch provides accurate & continuous monitoring of the 3 key leading indicators of patient deterioration: heart rate (HR), respiration rate (RR) & axillary temperature (T). Sensium wirelessly communicates this physiological data via safe & secure low power wireless communication to the Sensium bridges placed through the ward area.
 
The bridges are connected into the hospital IT system, & software installed on the hospital network allows patient data to be seamlessly conveyed. Crucially, notifications can be configured to work with hospital pager systems/mobile notification devices, giving the clinical team data when they need it, where they need it. To save time & ensure accuracy Sensium can be easily integrated with the hospital admission, discharge, transfer systems & electronic medical records.
 
Sensium allows patients to ambulate freely, untethered to static & expensive equipment whilst still having the reassurance of continuous monitoring.
 
The 3 most serious, costly & avoidable care incidents in unmonitored patients are: Sepsis, Cardiac arrest, Respiratory depression. 
  • In Britain more than 100k people suffer from severe sepsis each year. 37k of them will die from the disease. Each case of severe sepsis costs the NHS £20k meaning treatment costs £2bn a year.
  • There are approx 25,428 in-hospital cardiac arrests in the UK per year. More than 80% of hospitalised patients who suffer a cardiac arrest do not recover.
  • 1 in 100 patients treated with opioids for moderate to severe post-operative pain will experience events related to respiratory depression. 17 In the UK there are approx 7m operations performed each year resulting in a potential 70k cases of respiratory depression.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
75% of all adverse events & preventable deaths occur outside the ICU in unmonitored beds.

All hospitalised patients are at risk of deterioration but most catastrophic incidents are preceded by periods of change & abnormality in patient’s vital signs. If these changes in vital signs are detected & reacted to in a timely fashion then a significant proportion of costly patient deterioration can be avoided.
 
Currently approx. 10% of patients are harmed during their hospital stay & this represents a cost to the NHS of over £2.5b just to cover the additional length of stay for these patients. Improved monitoring regimes & early detection of deterioration is key to reducing this significant burden.
 
Sensium notifies the clinical team of patient deterioration allowing intervention before the condition worsens, thereby improving patient outcomes, shortening hospital stays & lowering treatment costs. It enables nurses to prioritise patient care where it is needed most.
 
Sensium is focussed exclusively on general care clinicians whose patients currently do not have the safety & security of continuous vital sign monitoring.
 
The system is configurable to display up to 24 hours of vital signs trend data. Highly flexible, Sensium allows clinicians to configure alert levels for each vital sign as appropriate to their clinical environment.
 
For the Clinician:
  • Real-time, early detection & notification of patient deterioration
  • Ability to access information at the nurse station or via other web-enabled devices
  • Integrates with existing workflow without customisation
For the Hospital:
  • Improves patient recovery & reduced length of stay
  • Avoids high cost treatments through early detection
  • Quick & easy to integrate into existing systems
For the Patient:
  • Non-intrusive, lightweight & comfortable to wear
  • Provides reassurance of continuous monitoring
  • Non-restrictive, allowing freedom of movement
Patient deterioration is a significant & growing problem but there is a mounting body of published evidence that supports early identification of the changes in physiology as the most critical factor in avoiding these dangerous & costly episodes. Studies suggest that the greatest area for improvement is not treating the deteriorated patient but more importantly early identification of the deteriorating patient. Delayed recognition of the signs of patient decline is the strongest predictor of patient mortality. To view the evidence, along with our case studies, click here.


Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
With ageing populations driving healthcare demand & heightened expectations of quality of life during & post medical treatment the NHS is under increasing pressure to achieve more with less.
 
Cost effective patient monitoring regimes will become increasingly important to:
  • Improve patient outcomes
  • Reduce care costs associated with expensive & largely avoidable patient deterioration episodes
  • Drive clinical effectiveness through data & evidence-based decision making
The increasing incidence of sepsis is likely to be due to people living longer & more medical/surgical interventions being performed. People with co-morbidities are more likely to survive their illness & for longer than before, which leads to much of the hospital-acquired sepsis that now occurs.
 
Data for finished discharge episodes with a primary or secondary diagnosis of sepsis for patients in England 2010-15 is below.



On average each UK Acute Trust will spend £13m on sepsis treatment & management annually.

The chart below is from Key statistics from the National Cardiac Arrest Audit 2015/16 report, based on data for in-hospital cardiac arrests in NHS acute hospitals.
 

Cardiac arrests are usually preceded by measurable changes in vital signs, by monitoring & reacting to these changes a significant proportion of in-hospital cardiac arrest deaths can be predicted & ultimately prevented.
 
Postoperative opioid-induced respiratory depression is a significant cause of death & brain damage. The Anaesthesia Closed Claims Project database of 9,799 claims was reviewed by 3 authors reviewing 357 claims that occurred 1990/2009 for the likelihood of RD using literature-based criteria. 97% were judged as preventable with better monitoring & response.



Deterioration can happen between observation rounds. If a patient deteriorates between these rounds the warning signs can go undetected for hours potentially leading to serious & costly consequences.
 
Working as your early warning system, Sensium provides affordable, real-time monitoring for patients:
  • Notifies of deterioration: delivered direct to relevant caregiver
  • Tracks HR, RR & axillary temperature: the 3 vital signs widely used in clinical practice as leading indicators of patient decline
  • Eliminates cross infection risk: through single use Sensium Patches
  • Allows free movement: for patients throughout the connected area
  • Offers seamless integration: server software easily integrates with ADT, AD, EMR etc
  • Comfortable for patients: light-weight, unobtrusive patch
Current and planned activity: 
We would like to engage with WMAHSN’s Patient Safety Collaborative Network through the Meridian online health innovation exchange to share our innovative solution to help deliver on improving patient safety across the West Midlands region. Specifically, Sensium would like to give hospitals in the West Midlands region the opportunity to realise the clinical and economic benefits associated with closer monitoring of patients’ vital signs.
 
Patients die because signs of deterioration are missed. There is a huge unfulfilled need for better monitoring of vital signs to identify high-risk patients who are on general hospital wards. Patient deterioration is often overlooked or not detected at all. One of the reasons is the intensity in nursing and frequency of vital signs monitoring which decreases from the Intensive Care via ward towards home. Early detection of physiological instability is crucial to prevent death and disability.



Further details: nightingale business case proposition.
 
What is the intellectual property status of your innovation?:
Aspects of the core technology are patented (14 separate patent families) to ensure freedom to operate.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
Clinical decision making improved via proactive digital remote monitoring. Together driving cost efficiencies, improving patient outcomes & avoiding hospital admissions. (CE Class 1a: data server sits within HSNC:  proven ¯ 67% admissions: scalable)
Overview of Innovation:
CliniTouch Vie is a digital health solution that reduces unnecessary hospital admissions.
 
CliniTouch Vie is a locked-down tablet with integrated 3G for intensive monitoring, education & empowerment with integrated direct messaging & video support.  Dynamic care plans & evidence-based algorithms enable automatic triage for healthcare teams.  Fast & simple to implement for the most at-risk patients. 
 
Launched in 2016, system is CE marked & MHRA approved. An evidence based digital health platform that clinically supports patients to better manage their condition. It has the flexibility to be adapted for data analytics & clinical decision-making support in chronic disease management (eg COPD, heart failure & diabetes), frailty & assisted discharge programmes for ambulant & non-ambulant patients
 
Clinical & economic evidence has been generated from trials with 300 respiratory patients [Ghosh et al, 2016, https://doi.org/10.12968/bjhc.2016.22.3.123]. Our evidence based digital solution increases patient access to care & promotes greater clinician-patient collaboration for the 15million people with LTCs. It drives timely, proactive intervention, minimising need for more acute costly care enabling sustainable long-term outcomes success
 
USPs:
Evidence based: Study published in the British Journal of HC Management showed 67% reduction in unscheduled COPD admissions & saving of £2,278 per patient pa. (NB: programme continues to deliver same level of savings)
 
Patient-centred: Personalisation of goals, metrics & parameters makes system truly patient centred providing real-time remote monitoring closer to home to improve patient experience & outcomes whilst generating savings
 
Secure & integrated: Data server sits within HSNC enabling it to push-pull data securely between healthcare provider & service users. Includes bespoke integrated secure video-conferencing platform with end-to-end encryption, allowing remote monitoring of medical conditions, improving quality of life & avoiding unnecessary admissions
 
Flexible Modular Architecture: Enables clinically validated question sets re: symptoms, to be easily tailored to specific therapy areas for qualitative data collection
 
Tiered Service: no upfront costs to NHS on PAYG basis:
- Digital platform integrated into existing healthcare pathways
- Light touch triage service informing local health teams of urgent priority patients for interventions
- Fully-Managed digital platform and nurse-led service providing triage & interventions
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
CliniTouch Vie has proven benefits and can be scaled up easily across the wider regions:
  • improved patient outcomes:
  • 67% reduction in COPD emergency admissions;
  • 13% improvement in CAT score
  • 97% of patients using CliniTouch Vie will further reduce distress and discomfort from conditions exacerbations
These were supported by:
  • improved access to healthcare: 24/7 access to healthcare, average 110 interventions per patient per annum (500% increase)
  • targeted and personalised health interventions: 7,250 personalised clinical interventions (data from 66 patients over 12 months)
  • data analytics: real-time clinical dashboards for clinical teams to prioritise patient needs; prioritised only 38% of patient clinical recordings required intervention within a 24-hour period
 

 
Patients are educated and supported to interpret the data to gain an improved understanding of their health status.CliniTouch Vie:
  1. Educates patients: supporting people to make health life choices through improving the understanding of their disease and self-management skills
  2. Enhances care for patients with chronic conditions: informing and engaging patients as part of NHS prevention agenda and creating a patient-provider collaboration
  3. Provides data analytics: making more targeted and personalised health interventions, by using disease specific algorithms to differentiate when one patient’s history or recent environmental exposures indicates a higher likelihood of flare up than another
  4. Improves patient safety: providing real time clinical and well-being data to identify early warning signs of health deterioration, medication adherence and self-management education
  5. Reduces hospital activity: providing real time management of high risk patients to prevent admissions
  6. Supports early discharge: providing hospital level diagnostics and monitoring in the home, enabling early discharge and can be used for remote clinical support post-surgery or in care-home settings
  7. Delivers workload efficiencies: supporting better patient self-management, reducing need for direct interventions and enabling staff to focus on priority patient care
  8. Offers locality wide cost savings: reduced demand leads to reduced NHS activity
 
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
The West Midlands priorities that CliniTouch Vie can address are:
  • P2: Long Term Conditions: whole system, person centred approach
  • P4: Wellness, healthy aging and prevention of illness
  • P8: Digital Health
 
Our vision is for CliniTouch Vie to contribute towards and support the West Midlands wider vision to develop a worldwide reputation for delivering healthcare through digital technologies, proven to deliver sustainable improved outcomes and create wealth.  We have already demonstrated that it can deliver on all fronts with high risk COPD patients and is being adopted for Heart Failure, Diabetes, Cancer and Frailty pathways.  With an ageing population, often with co-morbidities, it can be used to support a more patient-centric approach to health care services in the region.
 
CliniTouch Vie supports health and wealth benefits as is a flexible, real-time remote monitoring solution, facilitating earlier discharge, prevent readmissions, reduce risk of future exacerbations and improve self-management through our inbuilt education resources.  CliniTouch Vie delivers a proactive approach to tackling symptoms, preventing exacerbations and slowing health deterioration, resulting in reduced NHS costs.  The system has an extensive data collection of medical, lifestyle, biometric and daily activity.
 
Targeting patients who are at risk or have multiple hospital admissions could significantly reduce the NHS costs to the region as well as freeing up clinic and nurse time to manage a wider caseload more efficiently. With a more collaborative, integrated, patient centred approach, utilising proven remote digital health, the West Midlands could see a potential reduction in admissions by 60%+.
 
CliniTouch Vie is a locked-down tablet, with integrated 3G for intensive monitoring, education and empowerment with integrated direct messaging and video support.  Our dynamic care plans and evidence-based algorithms enable automatic triage for healthcare teams. 
 
The tablet comes in an easy to carry case with the peripherals and can be handed to the patient at home, in clinic or upon discharge and is linked directly to the clinician web-based management portal.  Data within CliniTouch Vie tablet is stored securely within the cloud and hosted on the N3.  This makes CliniTouch Vie easy to scale due to its low technology and estates requirement, whilst delivering a high quality clinical service.
Current and planned activity: 
Current:
Spirit Digital is part of Spirit Health Group and can provide one of the most comprehensive range of solutions to support patients of all ages, IT capabilities & levels of disease severity across a wide range of conditions e.g. respiratory, cardiovascular, diabetes, cancer, frailty.
 
Spirit is establishing research collaborations with academic institutions around evidence generation for AI and machine learning. This includes collaboration on a bid to the European Space Agency to further develop the technology using satellite data.

Planned:
Spirit Digital seeks WMAHSN support ta assist with introductions and marketing of CliniTouch Vie to local CCGs. 
 
Our planned NHS engagement activity programme for the next 12 months will be through a variety of channels:
  • Direct engagement with CCGs and community Trusts
  • Application to Digital Accelerator programme
  • Case study development & sharing
  • Presentations at national conferences
  • Creating user (clinicians & patients) video footage to share with CCGs
What is the intellectual property status of your innovation?:
We hold the IP for the technology and digital health algorithms.  We collaborate with Midlands based businesses, healthcare providers and universities and retain all IP for products and services.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
0
0
Votes

5.5 2
Votings

Created by

Share and Follow